Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors

Neurogastroenterol Motil. 2005 Dec;17(6):871-7. doi: 10.1111/j.1365-2982.2005.00717.x.

Abstract

When injected intracerebroventricularly (i.c.v.) in rats, nociceptin/orphanin FQ (N/OFQ) delays gastric emptying and increases plasma corticosterone levels. Our aim in this study was to investigate changes in gastric emptying of a phenol red meal, and the plasma corticosterone response to N/OFQ in adrenalectomized (ADX) rats, in ADX rats injected with corticosterone at 1, 24 and 72 h before the gastric emptying assay, and in intact rats i.c.v. pretreated with a glucocorticoid antagonist (RU486) and with a corticotropin-releasing factor receptor antagonist (alpha-helical CRF9-41). In adrenal intact rats, i.c.v. injection of N/OFQ (2.5 nmol rat-1) significantly delayed gastric emptying (by 70%) and increased plasma corticosterone concentrations. Conversely, in ADX rats, N/OFQ left gastric emptying unchanged. In ADX rats, corticosterone injected at 1, 24 and 72 h before the gastric emptying assay almost restored the N/OFQ-induced delay in gastric emptying. Finally, pretreatment with RU486- and alpha-helical CRF9-41 abolished the N/OFQ-induced inhibition of gastric emptying. These findings suggest that central N/OFQ inhibits gastric emptying through an integrated orphaninergic system-CRF interaction in which corticosterone plays a permissive role.

MeSH terms

  • Adrenalectomy
  • Animals
  • Anti-Inflammatory Agents / blood
  • Anti-Inflammatory Agents / pharmacology
  • Coloring Agents
  • Corticosterone / blood
  • Corticosterone / pharmacology
  • Corticotropin-Releasing Hormone / pharmacology
  • Gastric Emptying / drug effects*
  • Hormone Antagonists / administration & dosage
  • Hormone Antagonists / pharmacology
  • Hypothalamo-Hypophyseal System / drug effects
  • Hypothalamo-Hypophyseal System / physiology
  • Injections, Intraventricular
  • Male
  • Mifepristone / administration & dosage
  • Mifepristone / pharmacology
  • Nociceptin
  • Opioid Peptides / administration & dosage
  • Opioid Peptides / pharmacology*
  • Peptide Fragments / pharmacology
  • Phenolsulfonphthalein
  • Radioimmunoassay
  • Rats
  • Rats, Wistar
  • Receptors, Corticotropin-Releasing Hormone / antagonists & inhibitors
  • Receptors, Corticotropin-Releasing Hormone / drug effects*
  • Receptors, Glucocorticoid / antagonists & inhibitors
  • Receptors, Glucocorticoid / drug effects*

Substances

  • Anti-Inflammatory Agents
  • Coloring Agents
  • Hormone Antagonists
  • Opioid Peptides
  • Peptide Fragments
  • Receptors, Corticotropin-Releasing Hormone
  • Receptors, Glucocorticoid
  • Mifepristone
  • Corticotropin-Releasing Hormone
  • corticotropin releasing hormone (9-41)
  • Phenolsulfonphthalein
  • Corticosterone